Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

Clinical trial NCT03747939 · COMPLETED

Trial details

NCT number: NCT03747939
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Arthritis, Psoriatic

Start date: 2018-12-31
Primary completion: 2022-12-19
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.